These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

85 related articles for article (PubMed ID: 15881150)

  • 1. [Polypeptide bioregulators in the treatment of different-type abiotrophy of the retina].
    Khvatova AV; Khlebnikova OV; Meshkova GI; Tarasenkov AO; Shchuvatova EL; Stromova OV
    Vestn Oftalmol; 2005; 121(2):19-21. PubMed ID: 15881150
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Time course of bioelectrical activity of retina in patients with pigmented abiotrophy treated by deoxinate].
    Tsapenko IV; Riabina MV; Zueva MV; Eliseeva RF; Katsnel'son LA
    Vestn Oftalmol; 1999; 115(4):24-6. PubMed ID: 10523963
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A new method of treatment of retinitis pigmentosa/pigmentary abiotrophy.
    Katznelson LA; Khoroshilova-Maslova IP; Eliseyeva RF
    Ann Ophthalmol; 1990 May; 22(5):167-72. PubMed ID: 2369027
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Disease course of patients with X-linked retinitis pigmentosa due to RPGR gene mutations.
    Sandberg MA; Rosner B; Weigel-DiFranco C; Dryja TP; Berson EL
    Invest Ophthalmol Vis Sci; 2007 Mar; 48(3):1298-304. PubMed ID: 17325176
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Long-term follow-up of retinitis pigmentosa patients with multifocal electroretinography.
    Nagy D; Schönfisch B; Zrenner E; Jägle H
    Invest Ophthalmol Vis Sci; 2008 Oct; 49(10):4664-71. PubMed ID: 18566474
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Disease course of patients with pericentral retinitis pigmentosa.
    Sandberg MA; Gaudio AR; Berson EL
    Am J Ophthalmol; 2005 Jul; 140(1):100-6. PubMed ID: 15953579
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Results of the use of vasoactive preparation pikamilon in pigmented retinal abiotrophy].
    Davydova GA; Mukha AI
    Vestn Oftalmol; 1995; 111(3):20-2. PubMed ID: 7483195
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The association between visual acuity and central retinal thickness in retinitis pigmentosa.
    Sandberg MA; Brockhurst RJ; Gaudio AR; Berson EL
    Invest Ophthalmol Vis Sci; 2005 Sep; 46(9):3349-54. PubMed ID: 16123439
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Assessment of central retinal function in patients with advanced retinitis pigmentosa.
    Gerth C; Wright T; Héon E; Westall CA
    Invest Ophthalmol Vis Sci; 2007 Mar; 48(3):1312-8. PubMed ID: 17325178
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Results of retinalamine use in the treatment of tuberculous chorioretinitis].
    Aleksandrova TE; Aleksandrov EI
    Vestn Oftalmol; 2007; 123(2):25-8. PubMed ID: 17650606
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Longitudinal measures in children receiving ENCAD for hereditary retinal degeneration.
    Birch DG; Anderson JL; Fish GE
    Doc Ophthalmol; 1991; 77(3):185-92. PubMed ID: 1760967
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Observations of retinal pigmentary degeneration in children and adolescents (author's transl)].
    Dróbecka-Brydakowa E; Moszczyńska-Kowalska A
    Klin Oczna; 1977 Nov; 47(11):491-3. PubMed ID: 592665
    [No Abstract]   [Full Text] [Related]  

  • 13. Preservation of macular oscillatory potentials in eyes of patients with retinitis pigmentosa and normal visual acuity.
    Ikenoya K; Kondo M; Piao CH; Kachi S; Miyake Y; Terasaki H
    Invest Ophthalmol Vis Sci; 2007 Jul; 48(7):3312-7. PubMed ID: 17591903
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Results of a long-term dynamic observation of the use of the ENKAD preparation in pigment tapetoretinal abiotrophy].
    Katsnel'son LA; Trutneva KV; Bogoslovskiĭ AI; Miliavskaia TI; Sadykov IuKh
    Vestn Oftalmol; 1982; (2):28-30. PubMed ID: 7043877
    [No Abstract]   [Full Text] [Related]  

  • 15. Multifocal ERG reveals several patterns of cone degeneration in retinitis pigmentosa with concentric narrowing of the visual field.
    Janáky M; Pálffy A; Deák A; Szilágyi M; Benedek G
    Invest Ophthalmol Vis Sci; 2007 Jan; 48(1):383-9. PubMed ID: 17197558
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Retinal functional changes measured by microperimetry in neovascular age-related macular degeneration patients treated with ranibizumab.
    Parravano M; Oddone F; Tedeschi M; Schiano Lomoriello D; Chiaravalloti A; Ripandelli G; Varano M
    Retina; 2009 Mar; 29(3):329-34. PubMed ID: 19092732
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Natural course of ocular function in pigmented paravenous retinochoroidal atrophy.
    Choi JY; Sandberg MA; Berson EL
    Am J Ophthalmol; 2006 Apr; 141(4):763-5. PubMed ID: 16564825
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Multifocal visual evoked potentials to cone specific stimuli in patients with retinitis pigmentosa.
    Holopigian K; Shuwairi SM; Greenstein VC; Winn BJ; Zhang X; Carr RE; Hood DC
    Vision Res; 2005 Nov; 45(25-26):3244-52. PubMed ID: 16023698
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Penicillamine--a new therapy of retinitis pigmentosa.
    Gahlot DK
    Indian J Ophthalmol; 1981 Dec; 29(4):355-8. PubMed ID: 7346458
    [No Abstract]   [Full Text] [Related]  

  • 20. Longterm visual prognosis in Usher syndrome types 1 and 2.
    Sadeghi AM; Eriksson K; Kimberling WJ; Sjöström A; Möller C
    Acta Ophthalmol Scand; 2006 Aug; 84(4):537-44. PubMed ID: 16879578
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.